ChemicalBook Chinese Germany Japanese Korean

上海瀚香生物科技有限公司 Company Information
Company Name:    ShangHai Biochempartner Co.,Ltd
Tel:    177-54423994
Email:    2853530910@QQ.com
Nationality:    China
WebSite:    www.biochempartner.com
Product List:    8000
65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80
Product List
Navivumab 1443004-16-7
Trevogrumab 1429201-24-0
Lanadelumab 1426055-14-2
Dezamizumab 1662664-56-3
Aprutumab 1634620-63-5
Garetosmab 2097125-54-5
Letolizumab 1450981-87-9
Zanidatamab
Zolbetuximab 1496553-00-4
Cofetuzumab 1869928-62-0
Bermekimab 1401965-15-8
Inebilizumab 1299440-37-1
Prezalumab 1523164-68-2
Vadastuximab 1436390-63-4
Ranevetmab 1632282-27-9
Porgaviximab 1792982-55-8
Mosunetuzumab 1905409-39-3
Tiragolumab 1918185-84-8
Romilkimab 1399584-78-1
Lilotomab 1453362-55-4
Ascrinvacumab 1463459-96-2
Crotedumab 1452387-69-7
Birtamimab 1608108-91-3
Rozanolixizumab 1584645-37-3
Camrelizumab 1798286-48-2
Gedivumab 1807954-17-1
Lacnotuzumab 1831128-32-5
Tislelizumab 1858168-59-8
Ladiratuzumab 1629760-28-6
Netakimab 1796570-08-5
Opicinumab 1422268-07-2
Naratuximab 1622327-39-2
Vonlerolizumab 1638935-72-4
Flotetuzumab 1664355-28-5
Suvratoxumab 1629620-18-3
Tomuzotuximab 1646321-00-7
Talacotuzumab 1826831-79-1
Prasinezumab 1960462-19-4
Galcanezumab 1578199-75-3
Istiratumab 1509928-04-4
Carotuximab 1268714-50-6
Elezanumab 1791416-49-3
Brazikumab 1610353-18-8
Tomaralimab 1449294-76-1
Selicrelumab 1622140-49-1
Larcaviximab 1792982-56-9
Spartalizumab 1935694-88-4
Iladatuzumab 1906205-76-2
Ontamalimab 2098790-40-8
Monalizumab 1228763-95-8
Rivabazumab 1627519-84-9
Suptavumab 1629615-23-1
Lupartumab 1640971-88-5
Emapalumab 1709815-23-5
Azintuxizumab 1826819-57-1
Gilvetmab 1808081-43-7
Ianalumab 1929549-92-7
Atidortoxumab 1939108-95-8
Relatlimab 1673516-98-7
Cusatuzumab 1399546-01-0
Plozalizumab 1610761-46-0
Utomilumab 1417318-27-4
Frunevetmab 1708936-80-4
Timigutuzumab 1665274-14-5
Sirtratumab 1824663-82-2
Bemarituzumab 1952272-74-0
Tibulizumab 1849636-24-3
Pepinemab 2097151-87-4
Laprituximab 1622327-38-1
Timolumab 1073538-99-4
Lutikizumab 1791411-57-8
Telisotuzumab 1781223-80-0
Maftivimab 2135632-36-7
Varisacumab 1610010-60-0
Oleclumab 1803176-05-7
Mirikizumab 1884201-71-1
Eptinezumab 1644539-04-7
Fremanezumab 1655501-53-3
Obiltoxaximab 1351337-07-9
Ravulizumab 1803171-55-2
Indusatumab 1497400-26-6
Bleselumab 1453067-91-8
Navicixizumab 1638338-43-8
Setrusumab 1847394-95-9
Depatuxizumab 1471999-69-5
Crizanlizumab 1690318-25-2
Cosfroviximab 1792982-57-0
Loncastuximab 1875032-68-0
Berlimatoxumab 1939109-24-6
Crovalimab 1917321-26-6
Faricimab 1607793-29-2
Clivatuzumab Tetraxetan 1462876-11-4
Erenumab 1582205-90-0
Duvortuxizumab 1831098-91-9
Vunakizumab 1792181-33-9
Losatuxizumab 1801544-27-3
Lesofavumab 1807960-57-1
Gatipotuzumab 1264737-26-9
Gimsilumab 1648796-29-5
Zenocutuzumab 1969309-56-5
65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80
Copyright 2007©  ChemicalBook. All rights reserved.